Marc Finianos
Overview
Explore the profile of Marc Finianos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El Hady R, Fattouh N, Finianos M, Bitar I, Fakih T, Husni R, et al.
Sci Rep
. 2025 Feb;
15(1):4853.
PMID: 39924528
The opportunistic pathogen Candida parapsilosis is a major causative agent of candidiasis leading to death in immunocompromised individuals. Azoles are the first line of defense in their treatment. The purpose...
2.
Sobh G, Araj G, Finianos M, Sourenian T, Hrabak J, Papagiannitsis C, et al.
Front Cell Infect Microbiol
. 2024 Aug;
14:1466718.
PMID: 39145304
[This corrects the article DOI: 10.3389/fcimb.2024.1407246.].
3.
Sobh G, Araj G, Finianos M, Sourenian T, Hrabak J, Pappagianitsis C, et al.
Front Cell Infect Microbiol
. 2024 Jul;
14:1407246.
PMID: 38962322
Introduction: In the battle against multidrug-resistant bacterial infections, ceftazidime- avibactam (CZA) stands as a pivotal defense, particularly against carbapenemresistant (CR) Gram-negative pathogens. However, the rise in resistance against this drug...
4.
El Hady R, Fattouh N, Finianos M, Bitar I, Husni R, Khalaf R
Res Sq
. 2024 Jun;
PMID: 38903078
The opportunistic fungal pathogen is a major causative agent of candidiasis leading to death in immunocompromised individuals. Azoles are the first line of defense in treatment by inhibiting involved in...
5.
Fattouh N, Husni R, Finianos M, Bitar I, Khalaf R
Mycoses
. 2024 May;
67(6):e13750.
PMID: 38813959
Background: The prevalence of Candida glabrata healthcare-associated infections is on the rise worldwide and in Lebanon, Candida glabrata infections are difficult to treat as a result of their resistance to...
6.
Hachem S, Fattouh N, Chedraoui C, Finianos M, Bitar I, Khalaf R
J Fungi (Basel)
. 2024 May;
10(5).
PMID: 38786702
Background: The pathogenic fungus is a leading agent of death in immunocompromised individuals with a growing trend of antifungal resistance. Methods: The purpose is to induce resistance to drugs in...
7.
Bitar I, Papagiannitsis C, Kraftova L, Mattioni Marchetti V, Petinaki E, Finianos M, et al.
Front Microbiol
. 2023 Jan;
13:993240.
PMID: 36687644
Background: VIM metallo-β-lactamases are enzymes characterized by the ability to hydrolyze all β-lactams. Usually, -like genes are carried by class 1 integrons. In the Czech Republic, only sporadic cases of...
8.
Reslan L, Youssef N, Boutros C, Assaf-Casals A, Fayad D, Khafaja S, et al.
Expert Rev Vaccines
. 2022 Nov;
21(12):1905-1921.
PMID: 36342411
Background: The impact of pneumococcal conjugate vaccines (PCVs) on the burden of invasive pneumococcal disease (IPD) and serotype distribution was examined across age groups from data collected by the Lebanese...
9.
Finianos M, Kraftova L, Papagiannitsis C, Adamkova V, Hrabak J, Bitar I
J Glob Antimicrob Resist
. 2022 Mar;
29:116-119.
PMID: 35231657
Objectives: The aim of the study is to characterise the genomic features of three GES-producing Enterobacterales isolates from Czech hospitals. Methods: In 2020, during a routine screening of the hospital's...
10.
Reslan L, Araj G, Finianos M, El Asmar R, Hrabak J, Dbaibo G, et al.
Front Microbiol
. 2022 Feb;
12:770635.
PMID: 35145489
Background: The globally emerging pathogens poses heavy burden to the healthcare system. Their molecular analyses assist in understanding their epidemiology, dissemination, treatment, and control. This study was warranted to describe...